Rocket Lab is benefiting from increased ETF inflows and strong sector momentum, supported by its leading role in small-lift rocket launches and the upcoming Neutron medium-lift vehicle. Despite a high current valuation with an EV/Sales ratio of 124x trailing twelve months, projections show a potential compression to 37x by 2028 if execution goes as planned and Neutron scales successfully. The company has a $2.2 billion backlog, 46% year-over-year revenue growth, and a 38.2% gross margin, supporting a buy rating. Key upcoming catalysts include the Neutron launch expected in Q4 and the potential IPO of SpaceX. Additionally, Blue Origin's New Glenn rocket failure is seen as neutral to positive for Rocket Lab's medium-lift prospects, not affecting its competitive position.
On December 1, 2025, YieldMax Ultra Option Income Strategy ETF (ULTY) executed a 1-for-10 reverse split, raising its share price tenfold but not increasing investor value. The fund charges a high 1.24% expense ratio, significantly more than comparabl...
YieldMax Ultra Option Income Strategy ETF (ULTY) promises a high annualized yield near 62% through weekly distributions by selling options on volatile tech stocks. However, its total return over the past year was -4.8%, far below the S&P 500's 22% ga...
